The novel BRDT inhibitor NHWD870 shows potential as a male contraceptive in mice [PDF]
Acta Biochimica et Biophysica Sinica, 2022 Small molecule inhibitors of the bromodomain and extraterminal domain (BET) family proteins have emerged as promising options not only for the treatment of multiple cancers but also for disturbing the process of sperm maturation with potential for use as
Wu Sixian +9 more
doaj +2 more sources
Nigerian Journal of Medicine, 2020 Introduction: Sub-Saharan Africa continues to carry the full consequences of health and socioeconomic impact of HIV, with about 25.8 million and 66% of people with HIV infection living in the region. The overall prevalence of contraceptive use in Nigeria
Ayandunmola F Oyegoke, Aisha Abubakar
doaj +2 more sources
KAP Study on Contraception of First Year Male Students in Khon Kaen University
Thai Journal of Obstetrics and Gynaecology, 2015 Objective:To study knowledge, attitude, and practice of the first year male Khon Kaen university students regarding to contraceptionMaterials and Methods:A cross sectional descriptive study was conducted, using anonymous self-administered questionnaires,
Khotchawan Supa +4 more
doaj +2 more sources
Review of rationale and progress toward targeting cyclin-dependent kinase 2 (CDK2) for male contraception†. [PDF]
Biol Reprod, 2020 Cyclin-dependent kinase 2 (CDK2) is a member of the larger cell cycle regulating CDK family of kinases, activated by binding partner cyclins as its name suggests.
Faber EB, Wang N, Georg GI.
europepmc +2 more sources
Male contraception: Focus on behavioral and barrier methods [PDF]
AndrologyMale contraception includes various methods designed to prevent pregnancy by focusing on the male's role in reproduction.
Zsolt Kopa +4 more
openalex +2 more sources
Male Contraception: Research, New Methods, and Implications for Marginalized Populations
American Journal of Men's Health, 2017 The majority of research on contraception has focused on manipulating the female reproductive system. Recent studies have identified novel contraceptives for males, including hormonal- and nonhormonal-based therapeutics. Although these new contraceptives
Olivia Plana BA
doaj +2 more sources
Male contraception: where are we going and where have we been? [PDF]
BMJ Sex Reprod Health, 2019 Progress in developing new reversible male contraception has been slow. While the hormonal approach has been clearly shown to be capable of providing effective and reversible contraception, there remains no product available.
Reynolds-Wright JJ, Anderson R.
europepmc +2 more sources
The future of male contraception: a fertile ground. [PDF]
Transl Androl Urol, 2018 The continued and rapid expansion of the Earth’s population mandates the need for safe and effective measures of contraception. While a plethora of options exist for women, methods of contraception for the male partner are limited to condoms and ...
Khourdaji I +4 more
europepmc +2 more sources
Strategies for developing retinoic acid receptor alpha-selective antagonists as novel agents for male contraception. [PDF]
Eur J Med Chem, 2023 Al Noman MA +12 more
europepmc +3 more sources
Can the evolution of male contraception lead to a revolution? Review of the current state of knowledge. [PDF]
Cent European J Urol, 2018 Introduction Great advances in medical research concerning methods of contraception have been achieved in recent years, however, more than 25% of couples worldwide still rely on condoms – a method with poor efficacy. Even though there is a spectrum of 11
Frankiewicz M, Połom W, Matuszewski M.
europepmc +2 more sources